GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » FCF Margin %

Nortem Biogroup (XPAR:MLBIO) FCF Margin % : 0.00% (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nortem Biogroup's Free Cash Flow for the six months ended in Dec. 2022 was €0.00 Mil. Nortem Biogroup's Revenue for the six months ended in Dec. 2022 was €6.98 Mil. Therefore, Nortem Biogroup's FCF Margin % for the quarter that ended in Dec. 2022 was 0.00%.

As of today, Nortem Biogroup's current FCF Yield % is 0.00%.

The historical rank and industry rank for Nortem Biogroup's FCF Margin % or its related term are showing as below:


XPAR:MLBIO's FCF Margin % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 2.175
* Ranked among companies with meaningful FCF Margin % only.


Nortem Biogroup FCF Margin % Historical Data

The historical data trend for Nortem Biogroup's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup FCF Margin % Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
FCF Margin %
- -

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
FCF Margin % - -

Competitive Comparison of Nortem Biogroup's FCF Margin %

For the Packaged Foods subindustry, Nortem Biogroup's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortem Biogroup's FCF Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's FCF Margin % falls into.



Nortem Biogroup FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nortem Biogroup's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=0/6.983
=0.00 %

Nortem Biogroup's FCF Margin for the quarter that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=0/6.983
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nortem Biogroup FCF Margin % Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines